Vascular endothelial growth factor receptors in osteoclast differentiation and function

被引:94
作者
Aldridge, SE [1 ]
Lennard, TWJ [1 ]
Williams, JR [1 ]
Birch, MA [1 ]
机构
[1] Newcastle Univ, Sch Med, Sch Surg Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
VEGF; osteoclast; bone resorption; VEGF receptors; PIGF; VEGF-D;
D O I
10.1016/j.bbrc.2005.07.145
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteoclasts are derived from haematopoietic stem cell precursors of the monocyte/macrophage cell lineage, through interaction with factors that are believed to include M-CSF and RANKL. VEGF is a proangiogenic cytokine that has been shown to promote osteoclast differentiation and survival. In this study, we assessed the role of VEGF and its receptors in osteoclastogenesis, in vitro, by culturing osteoclast precursors in the presence of VEGF, VEGF receptor-specific ligands, and blocking antibodies to VEGF receptors. Activation of VEGFR1 in the presence of RANKL induces osteoclast differentiation. Stimulating the receptors individually induced increased resorption by osteoclasts compared to controls but not to the level observed when stimulating both receptors simultaneously. We have shown that VEGF induces osteoclast differentiation through its action on VEGFR1 The way in which VEGF mediates its effect on mature osteoclast activity, however, may be through its interaction with both receptor subtypes. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:793 / 798
页数:6
相关论文
共 31 条
[1]   Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells [J].
Abu-Ghazaleh, R ;
Kabir, J ;
Jia, H ;
Lobo, M ;
Zachary, I .
BIOCHEMICAL JOURNAL, 2001, 360 :255-264
[2]   Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2α [J].
Akeno, N ;
Czyzyk-Krzeska, MF ;
Gross, TS ;
Clemens, TL .
ENDOCRINOLOGY, 2001, 142 (02) :959-962
[3]   Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone [J].
Aldridge, SE ;
Lennard, TWJ ;
Williams, JR ;
Birch, MA .
BRITISH JOURNAL OF CANCER, 2005, 92 (08) :1531-1537
[4]  
ALLEN SH, 1989, J BONE MINER RES, V4, P47
[5]   Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[6]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P91
[7]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[8]   The vascular endothelial growth factor receptor Flt-1 mediates biological activities - Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis [J].
Clauss, M ;
Weich, H ;
Breier, G ;
Knies, U ;
Rockl, W ;
Waltenberger, J ;
Risau, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) :17629-17634
[9]  
Faust J, 1999, J CELL BIOCHEM, V72, P67, DOI 10.1002/(SICI)1097-4644(19990101)72:1<67::AID-JCB8>3.0.CO
[10]  
2-A